Moreover, grade 2/3 ovarian cancers were characterized by the increased expression of EMMPRIN and VEGF, increased CD105-MVD, and the lowered expression of bFGF compared to grade 1 ovarian cancers (P = 0.026, 0.019, 0.017, and 0.018, respectively). This evidence concerns the gene VEGFA and ovarian cancer.